IPO and Financial Overview - Aimfinity Investment Corp. I completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[136]. - The company has incurred losses since inception and currently has no revenue, relying on the sale of securities and loans for funding[138]. - Following the IPO, 4,076,118 AIMA New Units, or approximately 50.9% of the total, were redeemed by shareholders[147]. - The Company has $13,671,304 held in the Trust Account, which is intended to be used for completing the Initial Business Combination[167]. - An aggregate of approximately $23,778,577 was distributed from the Trust Account to redeeming Public Shareholders, with 1,996,522 AIMA New Units submitted for redemption, representing about 64.2% of the public units[151]. - The Company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees[166]. - The underwriters received a cash underwriting discount of $0.20 per Public Unit, totaling $1,610,000 at the closing of the IPO[178]. - A deferred fee of $0.35 per Public Unit, approximately $2,817,500 in total, will be payable upon the consummation of an initial business combination[178]. Merger and Business Combination - On October 13, 2023, Aimfinity entered into a merger agreement with Docter Inc., which will result in Docter becoming a wholly owned subsidiary of the newly formed PubCo[139]. - Up to 2.5 million additional PubCo Ordinary Shares may be issued to Docter Stockholders as contingent post-closing earnout consideration based on sales performance[142]. - The merger agreement includes provisions for earnout shares contingent on sales of at least 30,000 devices in fiscal year 2024 and 40,000 devices in fiscal year 2025[144]. - The merger agreement stipulates that the board of directors of PubCo will consist of five directors, with a new composition following the business combination[143]. - The Company entered into an Exchange Agreement to convert approximately $1.5 million of outstanding promissory notes into 150,000 private units in connection with the Docter Business Combination[160]. Financial Performance and Projections - As of March 31, 2025, the Company had a working capital deficiency of $3,715,292 and cash of $4,895[173]. - For the three months ended March 31, 2025, the Company reported a net income of $64,931, with interest income of $342,182 offset by operating costs of $277,251[164]. - The Company has not generated any revenues to date and does not expect to do so until after the completion of the Initial Business Combination[163]. Compliance and Regulatory Matters - A second extraordinary general meeting was held on April 23, 2024, where shareholders approved an extension of the deadline to consummate an initial business combination to January 28, 2025[148]. - The Company has the option to extend the deadline for consummating an initial business combination up to nine times, each by an additional one-month period[146]. - The Company received a notice from Nasdaq regarding non-compliance, leading to a transfer of listing to the OTC Market effective May 5, 2025[161]. Accounting and Reporting Standards - The company is evaluating the impact of adopting ASU No. 2024-03, which requires expanded income statement expense disclosures, effective for fiscal years commencing after December 15, 2026[180]. - Management does not anticipate that recently issued accounting standards will have a material effect on the company's financial statements[181]. - The company qualifies as a smaller reporting company and is not required to provide certain market risk disclosures[182].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________. For the fiscal year ended December 31, 2024 221 W 9th St, PMB 235 Wilmington, Delaware 19801 (Address of principal executive offices) (Zip Code) (425) 365-2933 Commission File Numbe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1641561 | | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) Cayman Islands 98-1641561 (State or oth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1641561 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organizat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________. Commission File Number: 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) Cayman Islands 98-1 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to __________ (425) 365-2933 (Registrant's telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) Cayman Islands 98-1641561 (State or oth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) Cayman Islands 98-1641561 (State or ot ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) Cayman Islands 98-1641 ...